Male breast cancer: Pathological and immunohistochemical features

被引:0
作者
Willsher, PC
Leach, LH
Ellis, IO
Bell, JA
Elston, CW
Bourke, JB
Blamey, RW
Robertson, JFR
机构
[1] CITY HOSP,PROFESSORIAL SURG UNIT,NOTTINGHAM NG5 1PB,ENGLAND
[2] CITY HOSP,DEPT HISTOPATHOL,NOTTINGHAM NG5 1PB,ENGLAND
[3] UNIV NOTTINGHAM HOSP,DEPT SURG,NOTTINGHAM NG7 2UH,ENGLAND
关键词
male breast cancer; pathology; immunohistochemistry;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Male breast cancer is uncommon and studies regarding the potential clinical relevance of the histopathological and immunohistochemical features are infrequently reported. Materials and Methods. We investigated the biological characteristics of forty-one male patients with invasive breast cancer by assessing histopathological and multiple immunohistochemical features. Results. The majority wets no special type (ductal) (37/41), lobular cancer was not seen. 73% were histological grade 3, 93% were positive for oestrogen receptor and 73% for progesterone receptor. The proportion of cancers positive for c-erbB-2 (45%), EGFR (20%), p53 (58%), MiB1 (40%), NCRC11 (78%), were similar to reports for female breast cancer. Nonsignificant associations between pool survival outcome and grade 3 tumours, and positive tissue staining for MiB1 and p53 were seen. Conclusions. While there are similarities in the biological features of breast cancel in males and females, some differences were identified Male breast cancer is more likely to be grade 3 tumours and hormone receptor positive.
引用
收藏
页码:2335 / 2338
页数:4
相关论文
共 29 条
[1]  
BLIN N, 1993, ONCOLOGY, V50, P408
[2]   MALE BREAST-CANCER [J].
BORGEN, PI .
SEMINARS IN SURGICAL ONCOLOGY, 1991, 7 (05) :314-319
[3]  
ELLIS IO, 1992, HISTOPATHOLOGY, V20, P479
[4]   IMMUNOCYTOCHEMICAL STAINING OF BREAST-CARCINOMA WITH THE MONOCLONAL-ANTIBODY NCRC-11 - A NEW PROGNOSTIC INDICATOR [J].
ELLIS, IO ;
HINTON, CP ;
MACNAY, J ;
ELSTON, CW ;
ROBINS, A ;
OWAINATI, AARS ;
BLAMEY, RW ;
BALDWIN, RW ;
FERRY, B .
BMJ-BRITISH MEDICAL JOURNAL, 1985, 290 (6472) :881-883
[5]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[6]   ESTROGEN-RECEPTOR AND EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN MALE BREAST-CARCINOMA [J].
FOX, SB ;
ROGERS, S ;
DAY, CA ;
UNDERWOOD, JCE .
JOURNAL OF PATHOLOGY, 1992, 166 (01) :13-18
[7]   LACK OF C-ERBB-2 ONCOPROTEIN EXPRESSION IN MALE BREAST-CARCINOMA [J].
FOX, SB ;
DAY, CA ;
ROGERS, S .
JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (11) :960-961
[8]  
FRIEDMAN MA, 1981, CANCER, V47, P134, DOI 10.1002/1097-0142(19810101)47:1<134::AID-CNCR2820470122>3.0.CO
[9]  
2-M
[10]  
KARDAS I, 1993, CANCER, V72, P1652, DOI 10.1002/1097-0142(19930901)72:5<1652::AID-CNCR2820720526>3.0.CO